Cargando…

Association of apolipoprotein A1 with osteoporosis: a cross-sectional study

SUMMARY: Higher levels of apolipoprotein A1 (ApoA1) were associated with higher risk of osteoporosis, which supports the argument that lipid metabolism is involved in bone metabolism. BACKGROUND: Although the current evidence shows that lipid metabolism and osteoporosis are closely related to cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaozhi, Wu, Xiaotao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979473/
https://www.ncbi.nlm.nih.gov/pubmed/36864426
http://dx.doi.org/10.1186/s12891-023-06264-6
_version_ 1784899733756575744
author Sun, Xiaozhi
Wu, Xiaotao
author_facet Sun, Xiaozhi
Wu, Xiaotao
author_sort Sun, Xiaozhi
collection PubMed
description SUMMARY: Higher levels of apolipoprotein A1 (ApoA1) were associated with higher risk of osteoporosis, which supports the argument that lipid metabolism is involved in bone metabolism. BACKGROUND: Although the current evidence shows that lipid metabolism and osteoporosis are closely related to cardiovascular disease, the association between ApoA1 and osteoporosis is still unknown. Therefore, the purpose of this study was to explore the relationship between ApoA1 and osteoporosis. METHODS: In this cross-sectional study, we included 7743 participants in the Third National Health and Nutrition Examination Survey. ApoA1 was regarded as an exposure variable and osteoporosis was considered as an outcome variable. Multivariate logistic regression analysis, sensitivity analysis, and receiver operator characteristic (ROC) were used to assess the association of ApoA1 with osteoporosis. RESULTS: Participants with higher ApoA1 had higher rates of osteoporosis compared to participants with lower ApoA1 (P <  0.05). Individuals with osteoporosis had higher levels of ApoA1 than individuals without osteoporosis (P <  0.05). In multivariate logistic regression analysis adjusted for age, sex, race, hypertension, diabetes, gout, hypotensive drugs, hypoglycemic drugs, systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, apolipoprotein B, blood urea nitrogen, albumin, uric acid, hemoglobin A1c, alkaline phosphatase and total calcium, higher ApoA1 was strongly associated with higher risk of osteoporosis, whether as a continuous variable or a categorical variable [Model 3, OR (95% CI), P value: 2.289 (1.350, 3.881), 0.002 and 1.712 (1.183, 2.478), 0.004]. And after excluding individuals with gout, the correlation between them remained and was significant (P <  0.01). And ROC analysis also showed that ApoA1 could predict the development of osteoporosis (AUC = 0.650, P <  0.001). CONCLUSION: ApoA1 was closely associated with osteoporosis.
format Online
Article
Text
id pubmed-9979473
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99794732023-03-03 Association of apolipoprotein A1 with osteoporosis: a cross-sectional study Sun, Xiaozhi Wu, Xiaotao BMC Musculoskelet Disord Research SUMMARY: Higher levels of apolipoprotein A1 (ApoA1) were associated with higher risk of osteoporosis, which supports the argument that lipid metabolism is involved in bone metabolism. BACKGROUND: Although the current evidence shows that lipid metabolism and osteoporosis are closely related to cardiovascular disease, the association between ApoA1 and osteoporosis is still unknown. Therefore, the purpose of this study was to explore the relationship between ApoA1 and osteoporosis. METHODS: In this cross-sectional study, we included 7743 participants in the Third National Health and Nutrition Examination Survey. ApoA1 was regarded as an exposure variable and osteoporosis was considered as an outcome variable. Multivariate logistic regression analysis, sensitivity analysis, and receiver operator characteristic (ROC) were used to assess the association of ApoA1 with osteoporosis. RESULTS: Participants with higher ApoA1 had higher rates of osteoporosis compared to participants with lower ApoA1 (P <  0.05). Individuals with osteoporosis had higher levels of ApoA1 than individuals without osteoporosis (P <  0.05). In multivariate logistic regression analysis adjusted for age, sex, race, hypertension, diabetes, gout, hypotensive drugs, hypoglycemic drugs, systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, apolipoprotein B, blood urea nitrogen, albumin, uric acid, hemoglobin A1c, alkaline phosphatase and total calcium, higher ApoA1 was strongly associated with higher risk of osteoporosis, whether as a continuous variable or a categorical variable [Model 3, OR (95% CI), P value: 2.289 (1.350, 3.881), 0.002 and 1.712 (1.183, 2.478), 0.004]. And after excluding individuals with gout, the correlation between them remained and was significant (P <  0.01). And ROC analysis also showed that ApoA1 could predict the development of osteoporosis (AUC = 0.650, P <  0.001). CONCLUSION: ApoA1 was closely associated with osteoporosis. BioMed Central 2023-03-02 /pmc/articles/PMC9979473/ /pubmed/36864426 http://dx.doi.org/10.1186/s12891-023-06264-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sun, Xiaozhi
Wu, Xiaotao
Association of apolipoprotein A1 with osteoporosis: a cross-sectional study
title Association of apolipoprotein A1 with osteoporosis: a cross-sectional study
title_full Association of apolipoprotein A1 with osteoporosis: a cross-sectional study
title_fullStr Association of apolipoprotein A1 with osteoporosis: a cross-sectional study
title_full_unstemmed Association of apolipoprotein A1 with osteoporosis: a cross-sectional study
title_short Association of apolipoprotein A1 with osteoporosis: a cross-sectional study
title_sort association of apolipoprotein a1 with osteoporosis: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979473/
https://www.ncbi.nlm.nih.gov/pubmed/36864426
http://dx.doi.org/10.1186/s12891-023-06264-6
work_keys_str_mv AT sunxiaozhi associationofapolipoproteina1withosteoporosisacrosssectionalstudy
AT wuxiaotao associationofapolipoproteina1withosteoporosisacrosssectionalstudy